Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TETHYS: Volulyte 6% vs Ionolyte in Trauma
NCT03338218Phase 4Completed
- Sponsor
- Fresenius Kabi
- Start
- Feb 2019
- Primary completion
- Jun 2022
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 7
01
Overview
A Phase 4 trial of hetastarch in hypovolemia, sponsored by Fresenius Kabi. Started Feb 2019; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT03338218.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03338218.